Location History:
- Hoef-Praebach, AT (2016)
- Graz, AT (2020)
Company Filing History:
Years Active: 2016-2020
Title: Christiane Luley: Innovator in Glycosylation Techniques
Introduction
Christiane Luley is a prominent inventor based in Graz, Austria, renowned for her contributions to the field of glycosylation. With a remarkable portfolio of two patents, Luley's work focuses on innovative methods that enhance our understanding and application of glycosyltransferase technologies, which are vital in the biotechnology sector.
Latest Patents
Luley's latest patents include a groundbreaking method for producing 2-O-glyceryl-alpha-D-glucopyranoside. This invention outlines a reliable technique to synthesize this compound utilizing a glucosyl donor and glycerol as a glucosyl acceptor. The process involves the use of sucrose phosphorylase, highlighting an important advancement in carbohydrate chemistry.
Another significant patent details the quantitative control of sialylation and specific mono-sialylation through the use of glycosyltransferase variants. Luley showcases her discovery of specific enzymatic activities exhibited by variants of human β-galactoside-α-2,6-sialyltransferase I, advancing the methodology for producing glycoproteins with precision.
Career Highlights
Throughout her career, Luley has held influential positions in notable organizations including Roche Diagnostics Operations, Inc. and Technische Universität Graz. Her work in these prestigious institutions has been pivotal in furthering research and development in the field of glycosylation and its applications in diagnostics and therapeutics.
Collaborations
Christiane Luley has collaborated with esteemed colleagues such as Bernd Nidetzky and Tibor Czabany. These partnerships have cultivated an environment of innovation, leading to significant advancements in her research endeavors and the broader scientific community.
Conclusion
Christiane Luley's contributions to the field of glycosylation through her patents exemplify her role as an important inventor. Her methodologies not only enhance our understanding of glycosylation but also hold the potential to transform biotechnological applications in various industries, solidifying her legacy as an innovator.